PharmaCorp Announces Grant of Stock Options

SASKATOON, Saskatchewan, July 02, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has granted a total of 827,603 options to purchase common ‎shares to directors, officers, employees and consultants of the Corporation, with an exercise price of $0.48 and ‎an expiry date of July 1, 2035, subject to approval of the TSX Venture Exchange.

Read more at globenewswire.com